viridiflorol

a strong feeding deterrent for the melaleuca weevil that retards larval development; structure in first source

Also Known As:

(1aR,4S,4aS,7R,7aS,7bS)-1,1,4,7-tetramethyldecahydro-1H-cyclopropa(e)azulen-4-ol

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Terpenes: 1461
    - viridiflorol: 4

Experts

1.	Akiel, Maaged A: 1 article (02/2022)
2.	Al-Asmari, Ahmed I: 1 article (02/2022)
3.	Alamri, Hassan S: 1 article (02/2022)
4.	Aljihani, Shokran A: 1 article (02/2022)
5.	Almuaysib, Amani: 1 article (02/2022)
6.	Alrfaei, Bahauddeen M: 1 article (02/2022)
7.	Alshehri, Ohoud Y: 1 article (02/2022)
8.	Bader, Ammar: 1 article (02/2022)
9.	Halwani, Majed A: 1 article (02/2022)
10.	Cardoso, Claudia Andrea Lima: 1 article (11/2016)

Related Diseases

1.	Neoplasms (Cancer) 02/01/2022 - "In conclusion, viridiflorol demonstrates cytotoxic and apoptotic ability in three different cancer cell lines (brain, breast and lung)." 02/01/2022 - "We tested the anticancer properties of viridiflorol at different concentrations ranging from 0.03 to 300 μM in vitro on three cancer cells including breast (MCF-7), lung (A549) and brain (Daoy). " 02/01/2016 - "Our results demonstrated that two of the constituents of Cyperus longus, viridiflorol and longiverbenone, should be investigated further as possible promising chemotherapeutic agents in cancer treatment." 02/01/2022 - "Viridiflorol is a natural volatile element that may work as anti-cancer compound. "
2.	Pleurisy (Pleuritis) 11/04/2016 - "Also EOAE and viridiflorol significantly inhibited carrageenan (Cg) induced pleurisy, reducing the migration of total leucocytes in mice by 62±5% (30mg/kg of oil), 35±8% (100mg/kg of oil), 71±5% (3mg/kg of viridiflorol) and 57±3% (30mg/kg of viridiflorol). " 11/04/2016 - "Both EOAE (30 and 100mg/kg) and viridiflorol (3 and 30mg/kg) by oral administration were assayed in carrageenan-induced mice paw oedema and pleurisy using subcutaneous injection of dexamethasone (0.5mg/kg) as the positive control. "
3.	Inflammation (Inflammations) 01/30/2023 - "EOAE (100 mg/kg, p.o.), viridiflorol (200 mg/kg, p.o.), and dexamethasone (1 mg/kg, s.c.) were tested by zymosan-articular inflammation and in open-field models. " 01/30/2023 - "EOAE, viridiflorol and dexamethasone significantly reduced mechanical hyperalgesia, edema, total leukocytes, polymorphonuclear cells, nitric oxide and protein exudation in the zymosan-induced articular inflammation model. "
4.	Hyperalgesia 01/30/2023 - "The local administration of viridiflorol (200 μg/paw, i.pl.) significantly inhibited mechanical hyperalgesia and edema induced by carrageenan, TNF-α and DOPA. " 01/30/2023 - "EOAE, viridiflorol and dexamethasone significantly reduced mechanical hyperalgesia, edema, total leukocytes, polymorphonuclear cells, nitric oxide and protein exudation in the zymosan-induced articular inflammation model. "
5.	Edema (Dropsy) 01/30/2023 - "The oral administration of EOAE (100 and 300 mg/kg, p.o.), viridiflorol (200 mg/kg, p.o.), morphine (1 mg/kg, s.c.) (MOR) and local administration of viridiflorol (100 μg/paw) significantly inhibited edema and nociception in formalin model. " 01/30/2023 - "The local administration of viridiflorol (200 μg/paw, i.pl.) significantly inhibited mechanical hyperalgesia and edema induced by carrageenan, TNF-α and DOPA. " 01/30/2023 - "EOAE, viridiflorol and dexamethasone significantly reduced mechanical hyperalgesia, edema, total leukocytes, polymorphonuclear cells, nitric oxide and protein exudation in the zymosan-induced articular inflammation model. "

Related Drugs and Biologics

1.	Dexamethasone (Maxidex)
2.	Carrageenan
3.	Zymosan
4.	Proteins (Proteins, Gene)
5.	Nitric Oxide (Nitrogen Monoxide)
6.	Morphine (MS Contin)
7.	Formaldehyde (Formol)
8.	Elements
9.	Dihydroxyphenylalanine (Dopa)

Related Therapies and Procedures

1.	Oral Administration
2.	Subcutaneous Injections